IRTC
iRhythm Technologies, Inc. NASDAQ Listed Oct 20, 2016$124.87
Mkt Cap $4.1B
52w Low $112.31
12.6% of range
52w High $212.00
50d MA $121.52
200d MA $157.09
P/E (TTM)
-86.9x
EV/EBITDA
-1557.1x
P/B
25.3x
Debt/Equity
4.8x
ROE
-29.2%
P/FCF
164.5x
RSI (14)
—
ATR (14)
—
Beta
1.18
50d MA
$121.52
200d MA
$157.09
Avg Volume
583.5K
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
699 8th Street · San Francisco, CA 94103 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | -0.56 | -0.43 | +23.2% | 129.16 | -1.8% | -6.5% | -1.3% | -0.9% | -0.3% | +6.1% | — |
| Feb 19, 2026 | AMC | 0.02 | 0.17 | +750.0% | 158.88 | -2.2% | -5.0% | -6.5% | -2.9% | -0.9% | +3.1% | — |
| Oct 30, 2025 | AMC | -0.36 | -0.06 | +83.3% | 184.12 | +12.7% | +1.7% | -1.2% | -2.1% | -0.3% | -1.7% | — |
| Jul 31, 2025 | AMC | -0.53 | -0.32 | +39.6% | 140.18 | +11.6% | +17.7% | +0.0% | -2.8% | -2.7% | +3.2% | — |
| May 1, 2025 | AMC | -0.89 | -0.95 | -6.7% | 108.59 | +10.3% | +20.7% | +3.5% | -0.4% | +0.7% | +0.6% | — |
| Feb 20, 2025 | AMC | -0.29 | 0.01 | +103.4% | 112.67 | +5.3% | +6.0% | -0.5% | -4.2% | -3.9% | -2.6% | — |
| Oct 30, 2024 | AMC | -0.55 | -1.26 | -129.1% | 75.77 | -10.3% | -4.4% | +3.6% | +8.5% | +6.4% | +3.3% | — |
| Aug 1, 2024 | AMC | -0.92 | -0.61 | +33.7% | 84.22 | -10.7% | -12.3% | -4.2% | +2.9% | -5.9% | +3.4% | — |
| May 2, 2024 | AMC | -0.99 | -1.47 | -48.5% | 110.88 | -1.8% | -7.4% | +4.0% | -0.6% | -7.0% | +1.1% | — |
| Feb 22, 2024 | AMC | -0.60 | -1.26 | -110.0% | 115.07 | -4.4% | -8.7% | +1.0% | +11.6% | -0.1% | +0.3% | — |
| Nov 2, 2023 | AMC | -0.65 | -0.89 | -36.9% | 79.16 | -0.8% | +5.2% | -2.8% | +1.9% | -6.7% | -5.6% | — |
| Aug 3, 2023 | AMC | -0.75 | -0.61 | +18.7% | 97.50 | +12.3% | +18.3% | -3.5% | +0.7% | +0.8% | +1.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | Needham | Maintains | Buy → Buy | — | $129.16 | $126.82 | -1.8% | -6.5% | -1.3% | -0.9% | -0.3% | +6.1% |
| May 1 | Canaccord Genuity | Maintains | Buy → Buy | — | $129.16 | $126.82 | -1.8% | -6.5% | -1.3% | -0.9% | -0.3% | +6.1% |
| May 1 | Wells Fargo | Maintains | Overweight → Overweight | — | $129.16 | $126.82 | -1.8% | -6.5% | -1.3% | -0.9% | -0.3% | +6.1% |
| May 1 | Evercore ISI | Maintains | Outperform → Outperform | — | $129.16 | $126.82 | -1.8% | -6.5% | -1.3% | -0.9% | -0.3% | +6.1% |
| May 1 | JP Morgan | Maintains | Overweight → Overweight | — | $129.16 | $126.82 | -1.8% | -6.5% | -1.3% | -0.9% | -0.3% | +6.1% |
| Apr 15 | Truist | Maintains | Buy → Buy | — | $123.23 | $122.27 | -0.8% | +1.0% | -1.4% | +2.2% | -0.3% | -4.8% |
| Apr 9 | Goldman Sachs | Maintains | Neutral → Neutral | — | $120.49 | $118.98 | -1.3% | -1.9% | -2.5% | +4.5% | +2.3% | +1.0% |
| Apr 6 | Evercore ISI | Maintains | Outperform → Outperform | — | $116.80 | $116.80 | +0.0% | +0.4% | +1.2% | +1.6% | -1.9% | -2.5% |
| Mar 11 | Citigroup | Maintains | Buy → Buy | — | $120.53 | $120.73 | +0.2% | -0.7% | -4.2% | -1.5% | +0.7% | +3.3% |
| Feb 23 | Truist | Maintains | Buy → Buy | — | $150.96 | $148.13 | -1.9% | -6.5% | -2.9% | -0.9% | +3.1% | -4.6% |
| Feb 20 | JP Morgan | Maintains | Overweight → Overweight | — | $158.88 | $155.36 | -2.2% | -5.0% | -6.5% | -2.9% | -0.9% | +3.1% |
| Feb 20 | Baird | Maintains | Outperform → Outperform | — | $158.88 | $155.36 | -2.2% | -5.0% | -6.5% | -2.9% | -0.9% | +3.1% |
| Feb 20 | Canaccord Genuity | Maintains | Buy → Buy | — | $158.88 | $155.36 | -2.2% | -5.0% | -6.5% | -2.9% | -0.9% | +3.1% |
| Feb 20 | Wells Fargo | Maintains | Overweight → Overweight | — | $158.88 | $155.36 | -2.2% | -5.0% | -6.5% | -2.9% | -0.9% | +3.1% |
| Jan 13 | Wells Fargo | Maintains | Overweight → Overweight | — | $168.99 | $167.70 | -0.8% | -8.0% | +5.0% | +5.4% | -2.8% | -0.9% |
| Jan 12 | Needham | Maintains | Buy → Buy | — | $179.43 | $176.28 | -1.8% | -5.8% | -8.0% | +5.0% | +5.4% | -2.8% |
| Jan 5 | Evercore ISI | Upgrade | In Line → Outperform | — | $175.22 | $176.53 | +0.7% | +5.2% | +0.3% | +1.3% | +1.0% | -5.2% |
| Dec 18 | Truist | Maintains | Buy → Buy | — | $167.38 | $168.31 | +0.6% | +0.7% | +3.4% | +3.1% | -0.7% | -1.5% |
| Dec 16 | Baird | Maintains | Outperform → Outperform | — | $169.00 | $168.80 | -0.1% | -0.7% | -0.3% | +0.7% | +3.4% | +3.1% |
| Dec 2 | Morgan Stanley | Maintains | Overweight → Overweight | — | $182.74 | $184.83 | +1.1% | -0.5% | +0.6% | -0.9% | -1.6% | -2.8% |
| Oct 31 | Canaccord Genuity | Maintains | Buy → Buy | — | $184.12 | $207.44 | +12.7% | +1.7% | -1.2% | -2.1% | -0.3% | -1.7% |
| Oct 31 | JP Morgan | Maintains | Overweight → Overweight | — | $184.12 | $207.44 | +12.7% | +1.7% | -1.2% | -2.1% | -0.3% | -1.7% |
| Oct 31 | Citigroup | Maintains | Buy → Buy | — | $184.12 | $207.44 | +12.7% | +1.7% | -1.2% | -2.1% | -0.3% | -1.7% |
| Oct 31 | Baird | Maintains | Outperform → Outperform | — | $184.12 | $207.44 | +12.7% | +1.7% | -1.2% | -2.1% | -0.3% | -1.7% |
| Oct 31 | Needham | Maintains | Buy → Buy | — | $184.12 | $207.44 | +12.7% | +1.7% | -1.2% | -2.1% | -0.3% | -1.7% |
| Oct 31 | Goldman Sachs | Maintains | Neutral → Neutral | — | $184.12 | $207.44 | +12.7% | +1.7% | -1.2% | -2.1% | -0.3% | -1.7% |
| Oct 31 | BTIG | Maintains | Buy → Buy | — | $184.12 | $207.44 | +12.7% | +1.7% | -1.2% | -2.1% | -0.3% | -1.7% |
| Oct 15 | Truist | Maintains | Buy → Buy | — | $176.84 | $176.84 | +0.0% | -0.7% | +3.0% | +0.4% | +0.2% | -2.2% |
| Oct 13 | BTIG | Maintains | Buy → Buy | — | $176.20 | $177.86 | +0.9% | +0.7% | -0.3% | -0.7% | +3.0% | +0.4% |
| Oct 10 | Baird | Maintains | Outperform → Outperform | — | $176.56 | $178.08 | +0.9% | -0.2% | +0.7% | -0.3% | -0.7% | +3.0% |
| Oct 7 | Evercore ISI | Maintains | In Line → In Line | — | $175.75 | $176.78 | +0.6% | +1.1% | +0.8% | -1.4% | -0.2% | +0.7% |
| Oct 7 | Citigroup | Maintains | Buy → Buy | — | $175.75 | $176.78 | +0.6% | +1.1% | +0.8% | -1.4% | -0.2% | +0.7% |
| Oct 1 | Goldman Sachs | Maintains | Neutral → Neutral | — | $171.99 | $171.84 | -0.1% | -2.6% | +3.8% | +1.0% | +0.1% | +1.1% |
| Sep 29 | Canaccord Genuity | Maintains | Buy → Buy | — | $170.81 | $173.33 | +1.5% | -0.8% | +1.5% | -2.6% | +3.8% | +1.0% |
| Aug 28 | Needham | Maintains | Buy → Buy | — | $169.79 | $169.23 | -0.3% | +1.0% | -0.9% | +0.6% | +3.2% | +3.2% |
| Aug 21 | Citigroup | Maintains | Buy → Buy | — | $163.20 | $163.20 | +0.0% | +2.1% | +1.5% | -2.0% | +1.4% | +1.1% |
| Aug 1 | Needham | Maintains | Buy → Buy | — | $140.18 | $156.45 | +11.6% | +17.7% | +0.0% | -2.8% | -2.7% | +3.2% |
| Aug 1 | Canaccord Genuity | Maintains | Buy → Buy | — | $140.18 | $156.45 | +11.6% | +17.7% | +0.0% | -2.8% | -2.7% | +3.2% |
| Aug 1 | Wells Fargo | Maintains | Overweight → Overweight | — | $140.18 | $156.45 | +11.6% | +17.7% | +0.0% | -2.8% | -2.7% | +3.2% |
| Aug 1 | Baird | Maintains | Outperform → Outperform | — | $140.18 | $156.45 | +11.6% | +17.7% | +0.0% | -2.8% | -2.7% | +3.2% |
| Aug 1 | JP Morgan | Maintains | Overweight → Overweight | — | $140.18 | $156.45 | +11.6% | +17.7% | +0.0% | -2.8% | -2.7% | +3.2% |
| Jul 15 | Morgan Stanley | Maintains | Overweight → Overweight | — | $138.91 | $138.78 | -0.1% | -3.6% | +2.3% | -0.9% | +0.4% | -0.5% |
| Jun 11 | Morgan Stanley | Maintains | Overweight → Overweight | — | $148.53 | $148.38 | -0.1% | -0.8% | -1.3% | -1.1% | +0.7% | +0.1% |
| May 22 | Citigroup | Maintains | Buy → Buy | — | $139.87 | $140.38 | +0.4% | +1.8% | +0.2% | +2.6% | -3.4% | +0.6% |
| May 2 | Baird | Maintains | Outperform → Outperform | — | $108.59 | $119.75 | +10.3% | +20.7% | +3.5% | -0.4% | +0.7% | +0.6% |
| May 2 | Needham | Maintains | Buy → Buy | — | $108.59 | $119.75 | +10.3% | +20.7% | +3.5% | -0.4% | +0.7% | +0.6% |
| May 2 | Canaccord Genuity | Maintains | Buy → Buy | — | $108.59 | $119.75 | +10.3% | +20.7% | +3.5% | -0.4% | +0.7% | +0.6% |
| May 2 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $108.59 | $119.75 | +10.3% | +20.7% | +3.5% | -0.4% | +0.7% | +0.6% |
| Feb 24 | Goldman Sachs | Maintains | Neutral → Neutral | — | $119.44 | $118.10 | -1.1% | -0.5% | -4.2% | -3.9% | -2.6% | +3.4% |
| Feb 21 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $112.67 | $118.64 | +5.3% | +6.0% | -0.5% | -4.2% | -3.9% | -2.6% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | Lawrence Brian LeeOff | Chief Technology Officer | Sell | 1,014 | $120.80 | $122K | 20,154 | -0.35% | — |
8-K
iRhythm Technologies, Inc. -- 8-K Filing
iRhythm Technologies reported Q1 2026 results, demonstrating operational performance in its digital health care platform focused on disease detection and prevention capabilities.
Apr 30
8-K · 4.01
!!! Very High
Unknown — 8-K 4.01: Auditor Change / Resignation
IRTC's auditor resignation suggests potential accounting disagreements or internal control concerns, which raises red flags about financial reliability and could pressure the stock until a reputable replacement is secured.
Apr 1
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Uncertainty around leadership transitions at UnitedHealth could create near-term stock volatility, though investors should monitor whether the successor demonstrates capability to navigate ongoing regulatory pressures in healthcare.
Mar 12
8-K
iRhythm Holdings, Inc. -- 8-K Filing
iRhythm Holdings reported fourth quarter and full year 2025 financial results, providing investors with updated performance metrics for the digital health company's device detection and disease prevention operations.
Feb 19
Data updated apr 25, 2026 4:17pm
· Source: massive.com